Published in Redox Biol on April 13, 2017
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA (2007) 11.87
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg (2006) 10.79
Vascular endothelial growth factor (VEGF) and its receptors. FASEB J (1999) 10.09
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med (2003) 8.95
Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med (1992) 8.94
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet (2013) 7.03
Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet (2004) 6.35
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res (2012) 4.19
Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest (2005) 4.14
Myocardial reperfusion: a double-edged sword? J Clin Invest (1985) 4.12
High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis (2004) 3.55
Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation (2012) 3.39
Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37
Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation (2009) 3.28
The prevalence of peripheral arterial disease in a defined population. Circulation (1985) 2.88
Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation (2003) 2.77
Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation (2003) 2.69
Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med (2011) 2.63
Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci U S A (1994) 2.62
Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest (2003) 2.60
Retracted Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res (2002) 2.56
Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells. Free Radic Biol Med (2008) 2.35
Antioxidants in Translational Medicine. Antioxid Redox Signal (2015) 2.32
Vascular ischaemia and reperfusion injury. Br Med Bull (2004) 2.28
Exercise training for claudication. N Engl J Med (2002) 2.26
Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2008) 2.17
Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am J Physiol Cell Physiol (2006) 2.16
Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation (2006) 2.02
Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation (2005) 1.98
Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J (2004) 1.90
Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res (2006) 1.85
A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. Nat Chem Biol (2008) 1.85
Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem (1999) 1.78
Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J (2015) 1.74
Phosphodiesterase inhibitors. Br J Pharmacol (2006) 1.72
Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr (2004) 1.71
Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J (2010) 1.67
Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim Biophys Acta (2010) 1.60
Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease. J Appl Physiol (1985) (2011) 1.52
Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia. Circ Res (2008) 1.52
Dark chocolate acutely improves walking autonomy in patients with peripheral artery disease. J Am Heart Assoc (2014) 1.50
Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol (1997) 1.49
Inflammation in peripheral artery disease. Circulation (2010) 1.47
Unacylated ghrelin induces oxidative stress resistance in a glucose intolerance and peripheral artery disease mouse model by restoring endothelial cell miR-126 expression. Diabetes (2014) 1.46
Therapeutic approaches for clinical ischemia and reperfusion injury. Shock (1997) 1.45
Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index. J Am Coll Cardiol (2016) 1.44
p62 at the interface of autophagy, oxidative stress signaling, and cancer. Antioxid Redox Signal (2012) 1.42
Impact of endovascular therapy on oxidative stress in patients with peripheral artery disease. Circ J (2014) 1.40
Oxidative stress: a concept in redox biology and medicine. Redox Biol (2015) 1.36
Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem (1997) 1.36
NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem (2007) 1.34
Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol (1995) 1.32
Stimulation of collateral artery growth: travelling further down the road to clinical application. Heart (2009) 1.32
Cardioprotective effects of vegetables: is nitrate the answer? Nitric Oxide (2006) 1.29
Hemoglobin oxygen fractional saturation regulates nitrite-dependent vasodilation of aortic ring bioassays. Am J Physiol Heart Circ Physiol (2007) 1.28
Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits. Circulation (2011) 1.27
Prevalence of peripheral arterial disease - results of the Heinz Nixdorf recall study. Eur J Epidemiol (2006) 1.27
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. J Vasc Surg (2009) 1.24
Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol (2015) 1.19
HIF-1 alpha protein as a target for S-nitrosation. FEBS Lett (2003) 1.17
The role of oxidative stress in diabetic vascular and neural disease. Free Radic Res (2003) 1.16
The effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase. Free Radic Biol Med (2001) 1.14
NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury. J Mol Med (Berl) (2012) 1.13
Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem (1990) 1.12
Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis. Am J Cardiol (2007) 1.12
Non-coronary atherosclerosis. Eur Heart J (2014) 1.11
Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid Redox Signal (2012) 1.10
Plgf-/-eNos-/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia. FASEB J (2006) 1.09
Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species. J Mol Cell Cardiol (2006) 1.07
Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage. Am J Physiol Regul Integr Comp Physiol (2008) 1.07
Free radical biology of the cardiovascular system. Clin Sci (Lond) (2012) 1.07
Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling. Cardiovasc Res (2010) 1.05
eNOS uncoupling in cardiovascular diseases--the role of oxidative stress and inflammation. Curr Pharm Des (2014) 1.04
Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in db/db mice. J Am Heart Assoc (2012) 1.03
Actions of "antioxidants" in the protection against atherosclerosis. Free Radic Biol Med (2012) 1.03
Nox2-containing NADPH oxidase deficiency confers protection from hindlimb ischemia in conditions of increased oxidative stress. Arterioscler Thromb Vasc Biol (2009) 1.02
Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved? Redox Biol (2015) 1.02
Oxidative stress and endothelial dysfunction: therapeutic implications. Ann Med (2011) 1.01
The hypoxia-inducible factor-2alpha is stabilized by oxidative stress involving NOX4. Antioxid Redox Signal (2010) 0.99
Redox signaling: bioinorganic chemistry at its best. J Inorg Biochem (2006) 0.98
Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models. Antioxid Redox Signal (2013) 0.98
Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease. J Transl Med (2013) 0.96
Oxidation-specific biomarkers and risk of peripheral artery disease. J Am Coll Cardiol (2013) 0.96
N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol (2001) 0.94
Inflammation, atherosclerotic burden and cardiovascular prognosis. Atherosclerosis (2007) 0.92
Oxidative damage in clinical ischemia/reperfusion injury: a reappraisal. Antioxid Redox Signal (2013) 0.92
Reciprocal regulation of Rac1 and PAK-1 by HIF-1alpha: a positive-feedback loop promoting pulmonary vascular remodeling. Antioxid Redox Signal (2010) 0.92
Clinical Relevance of Biomarkers of Oxidative Stress. Antioxid Redox Signal (2015) 0.91
Critical limb ischaemia is characterised by an increased production of whole blood reactive oxygen species and expression of TREM-1 on neutrophils. Atherosclerosis (2013) 0.90
Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective. Redox Biol (2014) 0.89
Pharmacological treatment and current management of peripheral artery disease. Circ Res (2015) 0.89
The role of exercise training in peripheral arterial disease. Vasc Med (2007) 0.89
CLINICAL PRACTICE. Peripheral Artery Disease. N Engl J Med (2016) 0.88
Glutaredoxin-1 up-regulation induces soluble vascular endothelial growth factor receptor 1, attenuating post-ischemia limb revascularization. J Biol Chem (2014) 0.88
Inorganic nitrite attenuates NADPH oxidase-derived superoxide generation in activated macrophages via a nitric oxide-dependent mechanism. Free Radic Biol Med (2015) 0.87
Impaired vascular endothelial growth factor A and inflammation in patients with peripheral artery disease. Angiology (2013) 0.87
Targeting vascular (endothelial) dysfunction. Br J Pharmacol (2016) 0.87